Home LiteratureArticle Details
PMID: 6407020 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

Pace JL, Russell SW, Schreiber RD, Altman A, Katz DH

Abstract

Antiviral and macrophage-priming activities in the supernatant medium of a subclone of a concanavalin A-stimulated mouse T-cell hybridoma were investigated. The two activities were associated with a molecular weight of approximately 50,000 and could not be separated by various approaches. Both activities were eliminated by a highly specific neutralizing antibody against mouse interferon-gamma, but not by antibody against interferon-alpha and -beta. The ratio of priming to antiviral activity in the hybridoma culture supernate was indistinguishable from the ratio obtained with mouse interferon-gamma prepared by recombinant DNA technology. It was concluded from these data that the priming activity in hybridoma culture supernates was attributable to interferon-gamma and that this mediator is one form of the lymphokine macrophage-activating factor. Interferon-gamma was greater than 800 times more efficient at priming mouse macrophages for tumor cell killing than was a mixture of interferon-alpha and -beta. This finding contributes to growing awareness that type II interferon may have greater immunoregulatory potential than type I interferons.

MeSH Terms
Animals Antibodies Cells, Cultured Concanavalin A Hybridomas/immunology Interferon Type I/immunology Interferon-gamma/immunology Macrophage Activation Macrophages/immunology Male Mice Mice, Inbred Strains T-Lymphocytes/immunology
Chemicals
Antibodies Interferon Type I Concanavalin A Interferon-gamma
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Pace J L
Russell S W
Schreiber R D
Altman A
Katz D H
References (30)
30 references, click to expand
  1. Detection of endotoxin in human blood and demonstration of an inhibitor.
    J Lab Clin Med. 1970 Jun;75(6):903-11 PMID: 5421075
  2. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.
    J Biol Chem. 1975 Apr 25;250(8):2911-19 PMID: 804483
  3. Inhibition of interferon action by vitamin A.
    J Gen Virol. 1975 Dec;29(3):315-24 PMID: 173796
  4. Macrophage tumor killing: influence of the local environment.
    Science. 1977 Jul 15;197(4300):279-82 PMID: 327547
  5. Interferon: an inducer of macrophage activation by polyanions.
    Science. 1977 Aug 12;197(4304):674-6 PMID: 877584
  6. The immunosuppressive effect of type II mouse interferon preparations on antibody production.
    Cell Immunol. 1977 Dec;34(2):193-206 PMID: 338162
  7. Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.
    Clin Exp Immunol. 1977 Nov;30(2):299-304 PMID: 203424
  8. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Cancer Res. 1978 Apr;38(4):1003-7 PMID: 346202
  9. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    J Immunol. 1978 Nov;121(5):2035-42 PMID: 712076
  10. Large-scale production and partial purification of mouse immune interferon.
    Infect Immun. 1979 Jan;23(1):80-6 PMID: 422237
  11. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells.
    J Reticuloendothel Soc. 1979 Sep;26(3):283-93 PMID: 228037
  12. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.
    Cell Immunol. 1980 Feb;49(2):390-4 PMID: 6986204
  13. Classification of interferons with antibody to immune interferon.
    Cell Immunol. 1980 Jul 15;53(1):65-70 PMID: 6157486
  14. Construction of T cell hybridomas secreting allogeneic effect factor.
    J Exp Med. 1980 Oct 1;152(4):956-68 PMID: 6158551
  15. Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay.
    J Immunol Methods. 1980;37(3-4):225-32 PMID: 7005345
  16. Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection?
    Cell Immunol. 1981 Jan 15;57(2):427-39 PMID: 6163553
  17. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Eur J Immunol. 1981 Feb;11(2):110-4 PMID: 6163639
  18. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    J Immunol. 1981 May;126(5):1863-7 PMID: 7217671
  19. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    J Immunol. 1981 Aug;127(2):417-22 PMID: 6166671
  20. Activation of natural cytotoxicity of human peripheral blood mononuclear cells by interferon: a kinetic study and comparison of different interferon types.
    Br J Haematol. 1982 Jan;50(1):85-94 PMID: 6173059
  21. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines.
    J Immunol. 1982 Mar;128(3):1365-71 PMID: 6120196
  22. Expression of human immune interferon cDNA in E. coli and monkey cells.
    Nature. 1982 Feb 11;295(5849):503-8 PMID: 6173769
  23. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    J Immunol. 1982 Aug;129(2):550-6 PMID: 7045227
  24. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
    J Exp Med. 1982 Sep 1;156(3):677-89 PMID: 7050288
  25. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
    J Interferon Res. 1982;2(2):291-9 PMID: 6811671
  26. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
    J Reticuloendothel Soc. 1982 May;31(5):393-7 PMID: 6181257
  27. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.
    Nature. 1982 Oct 28;299(5886):833-6 PMID: 6290893
  28. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    J Immunol. 1982 Dec;129(6):2802-7 PMID: 6982943
  29. Evidence for the identity of murine gamma interferon and macrophage activating factor.
    J Interferon Res. 1982;2(4):519-32 PMID: 6815284
  30. Murine T-cell hybridomas that produce lymphokine with macrophage-activating factor activity as a constitutive product.
    Cell Immunol. 1982 Sep 1;72(1):195-201 PMID: 6184172
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1983-06-00
Pages
3782-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC394136
Subset
IM
Grants
NCI NIH HHS · CA 25803 · United States
NCI NIH HHS · CA 31199 · United States
NCI NIH HHS · CA 34120 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com